FCGR2A and rheumatoid arthritis: Another study in 429 Caucasian patients (from Spain) diagnosed with RA and undergoing treatment with IFX showed that individuals carrying the FCGR2A rs1801274-G allele had a lower therapeutic response to this BT (p = 0.04) [56].